Showing results (2041-2050 of 2,168) with videos related to

Sort By:
Pageof 217
Leukemia Research|January 19, 2016
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agentsAziz Nazha, Mikkael A Sekeres, Guillermo Garcia-Manero, et al.
The Journal of Knee Surgery|June 4, 2026
Midterm Outcomes Following Repair of Complex Meniscus Tears: A Retrospective Analysis of Failure Risk and Postoperative ComplicationsRobert J Myers, Kevin E Agner, Kyle S Huntley, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromeMohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Oncogene|April 25, 2012
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletionS Wei, X Chen, K McGraw, et al.
Nature|October 5, 2007
Phagocyte-derived catecholamines enhance acute inflammatory injuryMichael A Flierl, Daniel Rittirsch, Brian A Nadeau, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Free Radical Biology & Medicine|November 25, 2021
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trialEmil List Larsen, Laura K Kjær, Louise Lundby-Christensen, et al.
The Lancet. Oncology|February 24, 2009
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyPierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, et al.
Frontiers in Immunology|October 31, 2022
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-diseaseThomas Krüger, Rebekka Wehner, Maik Herbig, et al.
Pageof 217